MétaCan
Menu
Back to cohort
Record W3127172128 · doi:10.1136/lupus-2020-000433

The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research

2021· article· en· W3127172128 on OpenAlexafffund
Karin Tse, Sanjyot Sangodkar, Lauren Bloch, Kathleen Arntsen, Sang‐Cheol Bae, Ian N Bruce, Erin Connolly-Strong, Karen H. Costenbader, Bradley Dickerson, Thomas Dörner, Sydney Evans, Kenneth Kalunian, Amy Kao, Susan Manzi, Eric F. Morand, Sandra Raymond, Brad H. Rovin, Laura E. Schanberg, Joan M. Von Feldt, Victoria P. Werth, Angel Williams Derricott, David Zook, Timothy R. Franson, Kenneth Getz, Yaritza Peña, Leslie Hanrahan

Bibliographic record

VenueLupus Science & Medicine · 2021
Typearticle
Languageen
FieldMedicine
TopicSystemic Lupus Erythematosus Research
Canadian institutionsAurinia (Canada)
FundersMultiple Sclerosis SocietyGlaxoSmithKlineNational Institute for Health and Care ResearchMallinckrodt PharmaceuticalsNational Multiple Sclerosis Society
KeywordsMedicineStakeholderTimelineSystemic lupus erythematosusStakeholder engagementHealth careMedical educationFamily medicinePublic relationsPathologyDisease

Abstract

fetched live from OpenAlex

The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. To conduct this process, the ALPHA Project convened a multistakeholder Global Advisory Committee (GAC) of lupus experts and collected input from global audiences, including patients. In phase I, the ALPHA Project used expert interviews and a global survey of lupus experts to identify and categorise barriers into three overarching pillars: drug development, clinical care and access to care. In phase II, reported here, the GAC developed recommended actionable solutions to address these previously identified barriers through an in-person stakeholder meeting, followed by a two-round scoring process. Recommendations were assessed for feasibility, impact and timeline for implementation (FIT), where potential FIT component values were between 1 and 3 and total scores were between 3 and 9. Higher scores represented higher achievability based on the composite of the three criteria. Simplifying and standardising outcomes measures, including steroid sparing as an outcome (drug development) and defining the lupus spectrum (clinical care) ranked as the highest two priority solutions during the GAC meeting and received high FIT scores (7.67 and 7.44, respectively). Leveraging social media (access to care) received the highest FIT score across all pillars (7.86). Cross-cutting themes of many solutions include leveraging digital technology and applying specific considerations for special populations, including paediatrics. Implementing the recommendations to address key barriers to drug development, clinical care and access to care is essential to improving the quality of life of adults and children with lupus. Multistakeholder collaboration and guidance across existing efforts globally is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.443
metaresearch head score (Gemma)0.407
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.443
Threshold uncertainty score0.686

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.4430.407
Meta-epidemiology (narrow)0.0040.003
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0190.012
Science and technology studies0.0110.009
Scholarly communication0.0160.012
Open science0.0120.043
Research integrity0.0080.014
Insufficient payload (model declined to judge)0.0120.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.162
GPT teacher head0.440
Teacher spread0.278 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueLupus Science & MedicineSame topicSystemic Lupus Erythematosus ResearchFrench-language works237,207